UA126979U - METHOD FOR PHARMACOLOGICAL CORRECTION OF DISORDERS OF CENTRAL NERVOUS Cognitive Functions AND PSYCHOEMOTIONAL SPHERE AFTER KETHAMIN ANESTHESIS - Google Patents

METHOD FOR PHARMACOLOGICAL CORRECTION OF DISORDERS OF CENTRAL NERVOUS Cognitive Functions AND PSYCHOEMOTIONAL SPHERE AFTER KETHAMIN ANESTHESIS

Info

Publication number
UA126979U
UA126979U UAU201801588U UAU201801588U UA126979U UA 126979 U UA126979 U UA 126979U UA U201801588 U UAU201801588 U UA U201801588U UA U201801588 U UAU201801588 U UA U201801588U UA 126979 U UA126979 U UA 126979U
Authority
UA
Ukraine
Prior art keywords
disorders
central nervous
cognitive functions
kethamin
anesthesis
Prior art date
Application number
UAU201801588U
Other languages
Ukrainian (uk)
Inventor
Ігор Федорович Беленичев
Михайло Юрійович Курочкін
Ольга Ігорівна Риженко
Богдан Сергійович Бурлака
Ніна Вікторівна Бухтіярова
Original Assignee
Запорізький Державний Медичний Університет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Запорізький Державний Медичний Університет filed Critical Запорізький Державний Медичний Університет
Priority to UAU201801588U priority Critical patent/UA126979U/en
Publication of UA126979U publication Critical patent/UA126979U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Спосіб фармакологічної корекції порушень когнітивних функцій центральної нервової системи і психоемоційної сфери після кетамінової анестезії в експерименті включає застосування лікарського засобу. Лабораторним тваринам інтраназально протягом 3 діб вводять ноопепт у дозі 10 мг/кг та цереброкурин у дозі 200 мкл/кг один раз на добу, при цьому використовують лікарську форму гель.A method of pharmacological correction of disorders of the cognitive functions of the central nervous system and the psycho-emotional sphere after ketamine anesthesia in the experiment involves the use of a drug. Laboratory animals were administered intranasally for 3 days with noopept at a dose of 10 mg / kg and cerebrocurine at a dose of 200 μl / kg once daily using a gel dosage form.

UAU201801588U 2018-02-19 2018-02-19 METHOD FOR PHARMACOLOGICAL CORRECTION OF DISORDERS OF CENTRAL NERVOUS Cognitive Functions AND PSYCHOEMOTIONAL SPHERE AFTER KETHAMIN ANESTHESIS UA126979U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201801588U UA126979U (en) 2018-02-19 2018-02-19 METHOD FOR PHARMACOLOGICAL CORRECTION OF DISORDERS OF CENTRAL NERVOUS Cognitive Functions AND PSYCHOEMOTIONAL SPHERE AFTER KETHAMIN ANESTHESIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201801588U UA126979U (en) 2018-02-19 2018-02-19 METHOD FOR PHARMACOLOGICAL CORRECTION OF DISORDERS OF CENTRAL NERVOUS Cognitive Functions AND PSYCHOEMOTIONAL SPHERE AFTER KETHAMIN ANESTHESIS

Publications (1)

Publication Number Publication Date
UA126979U true UA126979U (en) 2018-07-10

Family

ID=62814482

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201801588U UA126979U (en) 2018-02-19 2018-02-19 METHOD FOR PHARMACOLOGICAL CORRECTION OF DISORDERS OF CENTRAL NERVOUS Cognitive Functions AND PSYCHOEMOTIONAL SPHERE AFTER KETHAMIN ANESTHESIS

Country Status (1)

Country Link
UA (1) UA126979U (en)

Similar Documents

Publication Publication Date Title
MX2020007625A (en) Mtor inhibitor, pharmaceutical composition and use thereof.
CR20210368A (en) Combination of dextromethorphan and bupropion for treating depression
PH12019500202A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
MX2019001308A (en) Spiro-lactam nmda modulators and methods of using same.
PH12019500207A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
MX2019001321A (en) Spiro-lactam nmda receptor modulators and uses thereof.
MX2019001322A (en) Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof.
AR060786A1 (en) CRYSTAL VARIATIONS OF (2S) - (4E) -N-METIL-5- [3- (5-ISOPROPOXIPIRIDIN) IL] -4-PENTEN-2-AMINA
MX2021004883A (en) Methods and compositions for treating sleep apnea.
AR073435A1 (en) PHARMACEUTICAL COMPOSITION OF MODIFIED RELEASE OF A RELAXING MUSCLE AND AN NSAID
PE20011049A1 (en) COMBINATION OF DRUGS FOR THE TREATMENT OF DEPRESSION AND RELATED DISORDERS INVOLVING MIRTAZAPINE
BR112015025252A2 (en) methods and compositions using 4-amino-2- (2,6-dioxo-piperidin-3-yl) -isoindoline-1,3-dione for treatment and management of central nervous system cancers
UA126979U (en) METHOD FOR PHARMACOLOGICAL CORRECTION OF DISORDERS OF CENTRAL NERVOUS Cognitive Functions AND PSYCHOEMOTIONAL SPHERE AFTER KETHAMIN ANESTHESIS
EA201591603A1 (en) NEW THERAPEUTIC COMBINATIONS MYRTAZAPINE FOR APPLICATION IN PAIN DISEASES
BRPI0408113A (en) methods for treating or preventing a central nervous system disorder, for controlling a central nervous system disorder and for reducing or preventing an adverse effect associated with the administration of a secondary active ingredient in a patient suffering from a central nervous system disorder, and pharmaceutical composition
BR112023000798A2 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING VENGLUTAT
PH12018500889A1 (en) Pharmaceutical preparation for delivery of porous material to large intestine or lower part of small intestine
WO2016077565A3 (en) Methods for chronic pain management and treatment using hcg
NZ760033A (en) Methods to treat opioid use disorder
UA130646U (en) METHOD FOR CORRECTION OF SEXUAL DYSFUNCTION IN REPRODUCTIVE AGE WOMEN WITH POSTHISTERECTOMIC SYNDROME
MX2022007304A (en) Use of lemborexant for treating insomnia.
PH12019501607A1 (en) Tapentadol nasal composition
Singh et al. Evaluation of diazepam-ketamine anaesthesia in butorphanol-xylazine premedicated mules
MA38310A1 (en) Combination drug comprising phenylephrine and paracetamol
WO2018231176A3 (en) Combinations of diclofenac and h2 receptor antagonists for the treatment of pain and inflammation